Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2011

01-10-2011 | Research Article

Drug-related problems in diabetes and transplant patients: an observational study with home visits

Authors: Patrick M. Eichenberger, Manuel Haschke, Markus L. Lampert, Kurt E. Hersberger

Published in: International Journal of Clinical Pharmacy | Issue 5/2011

Login to get access

Abstract

Objectives To get insight into the medication management of diabetes type 2 (DM) as well as solid organ transplant (Tx) patients and to analyse drug-related problems (DRPs) in order to explore opportunities for the provision of pharmaceutical care. Setting Seventy-nine Swiss community pharmacies offering internships for pharmacy students. Methods Diabetes and transplant patients were recruited in community pharmacies and were interviewed at home by fifth-year pharmacy students who were supervised by a trained investigator, using a specific interview guide developed for this study. Main outcome measure Pattern and frequency of DRPs and pattern of medication management. Results In total, 22 (Tx patients) and 54 (DM patients) home visits were carried out. Mean age of visited patients was 71.4 ± 8.1 years (DM) and 52.6 ± 13.8 years (Tx). Overall, 37.0% (DM) and 50.0% (Tx) of participants were female. We identified 7.4 ± 2.4 (mean ± SD) DRPs per visited patient, with considerable differences between Tx and DM patients (6.3 ± 1.7 vs. 7.8 ± 2.5). The most frequent DRPs were risk for non-adherence (DM: 61.1%; Tx: 77.3%), confusion of generic and trade names (DM: 74.1%; Tx: 27.3%), hoarding of over-the-counter medicines (DM: 48.1%; Tx: 4.5%) and prescription-only medicines (DM: 37.0%; Tx: 36.4%), gaps in knowledge about potential interactions (DM: 61.1%; Tx: 18.2%) and purpose of drugs (DM: 48.1%; Tx: 36.4%). Mean (SD) duration of the visits was 51.7 ± 21.4 min. Conclusion Visiting Tx and DM patients in their homes allowed the identification of a wide range of opportunities for pharmaceutical care as well as specific DRPs which most probably would have escaped a medication review in the pharmacy.
Literature
1.
go back to reference Pacini M, Smith RD, Wilson EC, Holland R. Home-based medication review in older people: is it cost effective? PharmacoEconomics. 2007;25(2):171–80.PubMedCrossRef Pacini M, Smith RD, Wilson EC, Holland R. Home-based medication review in older people: is it cost effective? PharmacoEconomics. 2007;25(2):171–80.PubMedCrossRef
2.
go back to reference Shaw J, Seal R, Pilling M. Room for review: a guide to medication review: the agenda for patients, practitioners and managers. London: Medicines Partnership; ISBN 0 9544028 0 4; 2002. Shaw J, Seal R, Pilling M. Room for review: a guide to medication review: the agenda for patients, practitioners and managers. London: Medicines Partnership; ISBN 0 9544028 0 4; 2002.
3.
go back to reference Stafford AC, Tenni PC, Peterson GM, Jackson SL, Hejlesen A, Villesen C, et al. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci. 2009;31(2):216–23.PubMedCrossRef Stafford AC, Tenni PC, Peterson GM, Jackson SL, Hejlesen A, Villesen C, et al. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci. 2009;31(2):216–23.PubMedCrossRef
4.
go back to reference Beech E, Brackley K. Medicines management. Part 1: domiciliary based medication for the elderly. Pharm J. 1996;256:620–2. Beech E, Brackley K. Medicines management. Part 1: domiciliary based medication for the elderly. Pharm J. 1996;256:620–2.
5.
go back to reference Hsia Der E, Rubenstein LZ, Choy GS. The benefits of in-home pharmacy evaluation for older persons. J Am Geriatr Soc. 1997;45(2):211–4.PubMed Hsia Der E, Rubenstein LZ, Choy GS. The benefits of in-home pharmacy evaluation for older persons. J Am Geriatr Soc. 1997;45(2):211–4.PubMed
6.
go back to reference Read RW, Krska J. Targeted medication review: patients in the community with chronic pain. Int J Pharm Pract. 1998;6:216–22.CrossRef Read RW, Krska J. Targeted medication review: patients in the community with chronic pain. Int J Pharm Pract. 1998;6:216–22.CrossRef
7.
go back to reference Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2004;58(6):648–64.PubMedCrossRef Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2004;58(6):648–64.PubMedCrossRef
8.
go back to reference Delate T, Chester EA, Stubbings TW, Barnes CA. Clinical outcomes of a home-based medication reconciliation program after discharge from a skilled nursing facility. Pharmacotherapy. 2008;28(4):444–52.PubMedCrossRef Delate T, Chester EA, Stubbings TW, Barnes CA. Clinical outcomes of a home-based medication reconciliation program after discharge from a skilled nursing facility. Pharmacotherapy. 2008;28(4):444–52.PubMedCrossRef
9.
go back to reference Finkers F, Maring JG, Boersma F, Taxis K. A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther. 2007;32(5):469–76.PubMedCrossRef Finkers F, Maring JG, Boersma F, Taxis K. A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther. 2007;32(5):469–76.PubMedCrossRef
10.
go back to reference Hugtenburg JG, Borgsteede SD, Beckeringh JJ. Medication review and patient counselling at discharge from the hospital by community pharmacists. Pharm World Sci. 2009;31(6):630–7.PubMedCrossRef Hugtenburg JG, Borgsteede SD, Beckeringh JJ. Medication review and patient counselling at discharge from the hospital by community pharmacists. Pharm World Sci. 2009;31(6):630–7.PubMedCrossRef
11.
go back to reference Krahenbuhl JM, Decollogny A, Bugnon O. Using the costs of drug therapy to screen patients for a community pharmacy-based medication review program. Pharm World Sci. 2008;30(6):816–22.PubMedCrossRef Krahenbuhl JM, Decollogny A, Bugnon O. Using the costs of drug therapy to screen patients for a community pharmacy-based medication review program. Pharm World Sci. 2008;30(6):816–22.PubMedCrossRef
12.
go back to reference Vuong T, Marriott J, Kong D, Siderov J. Implementation of a community liaison pharmacy service: a randomised controlled trial. Int J Pharm Pract. 2008;16:127–35.CrossRef Vuong T, Marriott J, Kong D, Siderov J. Implementation of a community liaison pharmacy service: a randomised controlled trial. Int J Pharm Pract. 2008;16:127–35.CrossRef
13.
go back to reference Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65(3):303–16.PubMedCrossRef Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65(3):303–16.PubMedCrossRef
14.
go back to reference Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. Br Med J. 2005;330(7486):293.CrossRef Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. Br Med J. 2005;330(7486):293.CrossRef
15.
go back to reference Krska J, Avery AJ. Evaluation of medication reviews conducted by community pharmacists: a quantitative analysis of documented issues and recommendations. Br J Clin Pharmacol. 2007;65(3):386–96.PubMedCrossRef Krska J, Avery AJ. Evaluation of medication reviews conducted by community pharmacists: a quantitative analysis of documented issues and recommendations. Br J Clin Pharmacol. 2007;65(3):386–96.PubMedCrossRef
16.
go back to reference Tinelli M, Bond C, Blenkinsopp A, Jaffray M, Watson M, Hannaford P. Patient evaluation of a community pharmacy medications management service. Ann Pharmacother. 2007;41(12):1962–70.PubMedCrossRef Tinelli M, Bond C, Blenkinsopp A, Jaffray M, Watson M, Hannaford P. Patient evaluation of a community pharmacy medications management service. Ann Pharmacother. 2007;41(12):1962–70.PubMedCrossRef
17.
go back to reference Sorensen L, Stokes JA, Purdie DM, Woodward M, Roberts MS. Medication management at home: medication risk factor prevalence and inter-relationships. J Clin Pharm Ther. 2006;31(5):485–91.PubMedCrossRef Sorensen L, Stokes JA, Purdie DM, Woodward M, Roberts MS. Medication management at home: medication risk factor prevalence and inter-relationships. J Clin Pharm Ther. 2006;31(5):485–91.PubMedCrossRef
18.
go back to reference Haugbolle LS, Sorensen EW. Drug-related problems in patients with angina pectoris, type 2 diabetes and asthma–interviewing patients at home. Pharm World Sci. 2006;28(4):239–47.PubMedCrossRef Haugbolle LS, Sorensen EW. Drug-related problems in patients with angina pectoris, type 2 diabetes and asthma–interviewing patients at home. Pharm World Sci. 2006;28(4):239–47.PubMedCrossRef
19.
go back to reference Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30(3):205–11.PubMedCrossRef Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30(3):205–11.PubMedCrossRef
20.
go back to reference Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12(3):176–80.PubMedCrossRef Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12(3):176–80.PubMedCrossRef
21.
go back to reference Eichenberger PM, Lampert ML, Vogel Kahmann I, Van Mil JWF, Hersberger KE. Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci. 2010;32(3):362–72.PubMedCrossRef Eichenberger PM, Lampert ML, Vogel Kahmann I, Van Mil JWF, Hersberger KE. Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci. 2010;32(3):362–72.PubMedCrossRef
22.
go back to reference Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.PubMedCrossRef Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.PubMedCrossRef
24.
go back to reference Pharmavista. (2009) Information for Health Care Professionals. e-mediat AG Bern. Pharmavista. (2009) Information for Health Care Professionals. e-mediat AG Bern.
25.
go back to reference Paulino EI, Bouvy ML, Gastelurrutia MA, Guerreiro M, Buurma H. Drug related problems identified by European community pharmacists in patients discharged from hospital. Pharm World Sci. 2004;26(6):353–60.PubMed Paulino EI, Bouvy ML, Gastelurrutia MA, Guerreiro M, Buurma H. Drug related problems identified by European community pharmacists in patients discharged from hospital. Pharm World Sci. 2004;26(6):353–60.PubMed
26.
go back to reference Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003;25(5):218–26.PubMedCrossRef Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003;25(5):218–26.PubMedCrossRef
27.
go back to reference Roughead EE, Barratt JD, Gilbert AL. Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf. 2004;13(2):83–7.PubMedCrossRef Roughead EE, Barratt JD, Gilbert AL. Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf. 2004;13(2):83–7.PubMedCrossRef
28.
go back to reference Westerlund T, Almarsdottir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci. 1999;21(6):245–50.PubMedCrossRef Westerlund T, Almarsdottir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci. 1999;21(6):245–50.PubMedCrossRef
29.
go back to reference Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–54.CrossRef Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–54.CrossRef
30.
go back to reference Jansà M, Hernández C, Vidal M, Nuñez M, Bertran MJ, Sanz S, et al. Multidimensional analysis of treatment adherence in patients with multiple chronic conditions. A cross-sectional study in a tertiary hospital. Patient Educ Couns. 2010;81(2):161–8.PubMedCrossRef Jansà M, Hernández C, Vidal M, Nuñez M, Bertran MJ, Sanz S, et al. Multidimensional analysis of treatment adherence in patients with multiple chronic conditions. A cross-sectional study in a tertiary hospital. Patient Educ Couns. 2010;81(2):161–8.PubMedCrossRef
31.
go back to reference Furnham A. Response bias, social desirability and dissimulation. Person Individ Diff. 1986;7(3):385–400.CrossRef Furnham A. Response bias, social desirability and dissimulation. Person Individ Diff. 1986;7(3):385–400.CrossRef
32.
go back to reference Chisholm MA. Enhancing transplant patients’ adherence to medication therapy. Clin Transplant. 2002;16(1):30–8.PubMedCrossRef Chisholm MA. Enhancing transplant patients’ adherence to medication therapy. Clin Transplant. 2002;16(1):30–8.PubMedCrossRef
33.
go back to reference Caskie G, Willis S, Warner SK, Zanjani F. Congruence of medication information from a brown bag data collection and pharmacy records: findings from the Seattle longitudinal study. Int J Pharm Pract. 2005;32(1):79–103. Caskie G, Willis S, Warner SK, Zanjani F. Congruence of medication information from a brown bag data collection and pharmacy records: findings from the Seattle longitudinal study. Int J Pharm Pract. 2005;32(1):79–103.
34.
go back to reference Nathan A, Goodyer L, Lovejoy A, Rashid A. ‘Brown bag’ medication reviews as a means of optimizing patients’ use of medication and of identifying potential clinical problems. Fam Pract. 1999;16(3):278–82.PubMedCrossRef Nathan A, Goodyer L, Lovejoy A, Rashid A. ‘Brown bag’ medication reviews as a means of optimizing patients’ use of medication and of identifying potential clinical problems. Fam Pract. 1999;16(3):278–82.PubMedCrossRef
Metadata
Title
Drug-related problems in diabetes and transplant patients: an observational study with home visits
Authors
Patrick M. Eichenberger
Manuel Haschke
Markus L. Lampert
Kurt E. Hersberger
Publication date
01-10-2011
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2011
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-011-9542-x

Other articles of this Issue 5/2011

International Journal of Clinical Pharmacy 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.